# Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

> **NCT05856513** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 24 (actual)

## Conditions studied

- Hepatic Impairment
- Pharmacokinetics

## Interventions

- **DRUG:** ZSP1273
- **DRUG:** ZSP1273
- **DRUG:** ZSP1273

## Key facts

- **NCT ID:** NCT05856513
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2023-07-04
- **Final completion:** 2023-07-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05856513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05856513, "Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05856513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*